IMMUNIC (IMUX) director Robert Nagel files initial insider Form 3

Rhea-AI Filing Summary

IMMUNIC, INC. director Robert Thorvald Nagel filed an initial ownership report on Form 3. This filing establishes his status as an insider of the company and provides the baseline record of his beneficial ownership in IMMUNIC’s securities as required by U.S. securities regulations. No transactions are reported.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nagel Robert Thorvald

(Last) (First) (Middle)

44 MONTGOMERY ST.

40TH FLOOR

(Street)

SAN FRANCISCO CA 94104

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/17/2026

3. Issuer Name and Ticker or Trading Symbol
IMMUNIC, INC. [ IMUX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ R. Thorvald Nagel	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the IMMUNIC (IMUX) Form 3 filing for Robert Thorvald Nagel report?

The IMMUNIC Form 3 filing reports that Robert Thorvald Nagel is an insider, serving as a director of the company. It is an initial statement of beneficial ownership and does not list any transactions or changes in his holdings.

Does the IMMUNIC (IMUX) Form 3 for Robert Thorvald Nagel show any share purchases or sales?

No, the Form 3 for Robert Thorvald Nagel shows no share purchases or sales. It is an initial ownership report with zero transactions, serving only to register his insider status and baseline beneficial ownership information.

What insider role does Robert Thorvald Nagel hold at IMMUNIC (IMUX) in this Form 3?

The Form 3 identifies Robert Thorvald Nagel as a director of IMMUNIC, INC. This confirms he is considered an insider under securities rules, triggering ongoing reporting obligations for future transactions in the company’s securities.

Why is IMMUNIC (IMUX) filing a Form 3 for Robert Thorvald Nagel?

Form 3 is filed to disclose that Robert Thorvald Nagel has become an insider of IMMUNIC as a director. It creates a starting record of his beneficial ownership, against which any future Form 4 or Form 5 transaction reports will be compared.

Does the IMMUNIC (IMUX) Form 3 indicate that Robert Thorvald Nagel is a 10% owner?

No, the Form 3 indicates that Robert Thorvald Nagel is not a ten percent owner. His insider status arises from serving as a director of IMMUNIC, rather than from holding a large ownership stake in the company.